0001181431-14-037473.txt : 20141128 0001181431-14-037473.hdr.sgml : 20141127 20141128164211 ACCESSION NUMBER: 0001181431-14-037473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141128 FILED AS OF DATE: 20141128 DATE AS OF CHANGE: 20141128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALAFI CAPITAL CO LLC CENTRAL INDEX KEY: 0001216017 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 141256102 MAIL ADDRESS: STREET 1: PO BOX 7338 CITY: BERKELEY STATE: CA ZIP: 94707 4 1 rrd419474.xml FORM 4 - ALAFI CAPITAL COMPANY, LLC X0306 4 2014-11-28 0 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001216017 ALAFI CAPITAL CO LLC 8 ADMIRAL DRIVE, SUITE 324 EMERYVILLE CA 94608 0 0 1 0 Common Stock 2014-11-28 4 P 0 35000 14.75 A 3594783 D This Form 4 reports a private transaction in which Alafi Capital Company, LLC (of which Christopher Alafi, Ph.D., one of the Issuer's directors, is a managing partner) purchased 35,000 shares of the Issuer's common stock from Sharon Mates, Ph.D., the Issuer's Chairman, President and Chief Executive Officer. /s/ Lawrence J. Hineline, Attorney-in-fact 2014-11-28